HSF1 and hepatocellular carcinoma: Statistical analysis of cohort studies indicated that 68.7% (n=46/67) of the HCC patients were HSF1-positive compared with 28.6% (n=6/21) of the normal liver biopsies (χ2=10.628, P=0.001; Table I), and HSF1 protein levels were significantly increased in HCC tissues.